Discordant neoplasms in monozygotic twins with a germline RECQL5 variant

Cancer Genetics · Published 2026-07-16 · DOI 10.1016/j.cancergen.2026.07.006

Authors (9)

Ammar Husami, Aaron Mochizuki, Qiaoning Guan, Wenying Zhang, Chinmayee Bhimarao Nagaraj, Corrie Fabelo, Christine Phillips, Brian Dawson, Sun Young Kim

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year

2026

Citation

Husami, A., Mochizuki, A., Guan, Q., et al. (2026). Discordant neoplasms in monozygotic twins with a germline RECQL5 variant. Cancer Genetics. https://doi.org/10.1016/j.cancergen.2026.07.006

Related articles

• Autophagy inhibition enhances PD-1 blockade efficacy in mismatch repair–proficient colorectal cancer · Cancer Genetics · 2026 · Same journal
• A decision-oriented framework for genomic testing across the prostate cancer continuum · Cancer Genetics · 2026 · Same journal
• Beyond ATRX: The heterogeneous basis of Alternative Lengthening of Telomeres in osteosarcoma · Cancer Genetics · 2026 · Same journal
• TFRC-mediated immune exclusion as a therapeutic vulnerability in cervical cancer: A comprehensive analysis based on the cancer immunoediting process · Cancer Genetics · 2026 · Same journal
• Genetic variations in base excision repair genes and the risk of developing hepatoblastoma: A five-center case-control study from East China · Cancer Genetics · 2026 · Same journal
• Persistent monosomy 7 in Philadelphia chromosome-negative cells without disease progression over nearly two decades of follow-up in chronic myeloid leukemia · Cancer Genetics · 2026 · Same journal
• Novel truncating WT1 germline variant in a case of familial Wilms tumor · Cancer Genetics · 2026 · Same journal
• Clinical utility and implementation of a virtual molecular tumor board in real-world oncology practice · Cancer Genetics · 2026 · Same journal
• Myeloid neoplasms with mutated KIT: comparative clinicopathologic analysis of D816 vs. non-D816 variants · Cancer Genetics · 2026 · Same journal
• Prohibitins in cancer: Multifaceted regulators of mitochondrial homeostasis, oncogenic signaling, tumor microenvironment, and therapeutic resistance · Cancer Genetics · 2026 · Same journal